Ultime notizie per Quantum Computing (NASDAQ:QUBT) Azioni

Quantum Computing

Quantum Computing Inc is an American company utilizing non-linear quantum optics (optical devices whose output due to quantum effects is exponentially, not linearly, related to inputs) to deliver quantum products for high-performance computing applications. QCi's products are designed to operate at room temperature and use low power at an affordable cost. The Company's portfolio of core technology and products offer new capabilities in the areas of high-performance computing, artificial intelligence, cyber security as well as remote sensing applications.

Quantum Computing Inc

Earnings

News

Comerica Q3 2024 Adj. EPS $1.37 Beats $1.16 Estimate, Sales $811.000M Miss $811.617M Estimate

HC Wainwright &amp; Co. analyst Joseph Pantginis reiterates Adlai Nortye (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ANL#NASDAQ">ANL</a>) with a Buy and maintains $9 price target.

Price Target

Reiteration

Analyst Ratings

HC Wainwright & Co. Reiterates Buy on Adlai Nortye, Maintains $9 Price Target

HC Wainwright &amp; Co. analyst Edward White maintains Aura Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AURA#NASDAQ">AURA</a>) with a Buy and raises the price target from $21 to $22.

AURA

HC Wainwright & Co. Maintains Buy on Aura Biosciences, Raises Price Target to $22

The collaboration supports the licensing of part of Curiosity Stream&#39;s content portfolio in China, Hong Kong, and Macau, bringing 56 unique titles, amounting to 148 hours of premium factual content, to audiences across these territories through various platforms. The deal encompasses a diverse range of programming, from short-form documentary series to premium long-form content.

CURI

Curiosity Inks Strategic Distribution Partnership With Off The Fence; Deal Broadens Company's Footprint Across China, Hong Kong, And Macau

Guidance

CVS's Q3 Results Won't Meet Wall Street's Expectations; Plans To Back Away From Current 2024 Guidance

HC Wainwright &amp; Co. analyst Heiko Ihle reiterates DRDGold (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DRD#NYSE">DRD</a>) with a Buy and maintains $13.25 price target.

HC Wainwright & Co. Reiterates Buy on DRDGold, Maintains $13.25 Price Target

-The Wall Street Journal
-The Wall Street Journal
<a href="https://www.wsj.com/health/healthcare/cvs-names-david-joyner-as-new-chief-executive-a0a73b27" title="https://www.wsj.com/health/healthcare/cvs-names-david-joyner-as-new-chief-executive-a0a73b27">https://www.wsj.com/health/healthcare/cvs-names-david-joyner-as-new-chief-executive-a0a73b27</a>

Management

CVS Naming Caremark President David Joyner As Its New CEO

HC Wainwright &amp; Co. analyst Heiko Ihle reiterates Avino Silver &amp; Gold Mines (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/ASM#AMEX">ASM</a>) with a Buy and maintains $1.5 price target.

HC Wainwright & Co. Reiterates Buy on Avino Silver & Gold Mines, Maintains $1.5 Price Target

Biotech

Large Cap

Health Care

General

The European Medicines Agency's Committee For Medicinal Products For Human Use Has Adopted A Positive Opinion, Recommending Approval Of Novo Nordisk's Alhemo (Concizumab) As The First Once-Daily Subcutaneous Prophylactic Treatment For People Aged 12 Years Or Older With Hemophilia A Or B With Inhibitors.

HC Wainwright &amp; Co. analyst Heiko Ihle reiterates First Majestic Silver (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AG#NYSE">AG</a>) with a Buy and maintains $8.5 price target.

HC Wainwright & Co. Reiterates Buy on First Majestic Silver, Maintains $8.5 Price Target

The combined companies for the trailing twelve months have generated $235 million in revenue, increasing approximately&nbsp;25%&nbsp;quarter-over-quarter.

BTTR

Better Choice Expects Combined 2025 Pro Forma Basis Revenue And EBITDA To Be Approximately +$270M, And +$10M, Respectively

Better Choice Says Continues To Make Progress Towards Closing Of Its Acquisition Of SRx Health Solutions; Expects Transaction To Close In Late Q4 Of This Year Or Early Q1 Of 2025

Needham analyst Ami Fadia reiterates Neumora Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NMRA#NASDAQ">NMRA</a>) with a Buy and maintains $23 price target.

NMRA

Needham Reiterates Buy on Neumora Therapeutics, Maintains $23 Price Target

Based on sales trends and order intake in recent years, it expects further market share gains with domestic Chinese OEMs in the coming years.
With the seasonally strong fourth quarter remaining of the year, it reaffirms&nbsp;guidance of around 9.5-10.0% adjusted operating margin for 2024, but to be at the low end of this range.
&nbsp;

Autoliv Now Expects Full Year 2024 Organic Sales Growth To Be 1% Instead Of Previously Expected 2% Due To Unfavorable Market Mix Development

Regions Finl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RF#NYSE">RF</a>) reported quarterly earnings of $0.57 per share which beat the analyst consensus estimate of $0.53 by 7.55 percent. This is a 16.33 percent increase over earnings of $0.49 per share from the same period last year. The company reported quarterly sales of $1.87 billion which beat the analyst consensus estimate of $1.80 billion by 3.78 percent. This is a 0.54 percent increase over sales of $1.86 billion the same period last year.

Earnings Beats

Regions Finl Q3 Adj $0.57 Beats $0.53 Estimate, Sales $1.87B Beat $1.80B Estimate

HC Wainwright &amp; Co. analyst Patrick Trucchio reiterates Alnylam Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALNY#NASDAQ">ALNY</a>) with a Buy and maintains $400 price target.

ALNY

HC Wainwright & Co. Reiterates Buy on Alnylam Pharmaceuticals, Maintains $400 Price Target

Autoliv (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALV#NYSE">ALV</a>) reported quarterly earnings of $1.84 per share which missed the analyst consensus estimate of $1.95 by 5.64 percent. The company reported quarterly sales of $2.56 billion which beat the analyst consensus estimate of $2.53 billion by 0.89 percent. This is a 1.58 percent decrease over sales of $2.60 billion the same period last year.

Earnings Misses

Autoliv Q3 2024 Adj EPS $1.84 Misses $1.95 Estimate, Sales $2.56B Beat $2.53B Estimate

HC Wainwright &amp; Co. analyst Amit Dayal reiterates Gevo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GEVO#NASDAQ">GEVO</a>) with a Buy and maintains $14 price target.

GEVO

HC Wainwright & Co. Reiterates Buy on Gevo, Maintains $14 Price Target

Needham analyst Ami Fadia reiterates Avadel Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVDL#NASDAQ">AVDL</a>) with a Buy and maintains $22 price target.

Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share

AVDL

Needham Reiterates Buy on Avadel Pharmaceuticals, Maintains $22 Price Target

Needham analyst Mayank Tandon maintains WNS (Hldgs) (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WNS#NYSE">WNS</a>) with a Buy and lowers the price target from $70 to $60.

Needham Maintains Buy on WNS (Hldgs), Lowers Price Target to $60

Warning: QUBT is at high risk of performing badly

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Quantum mechanics could very well unlock the next stage of modern computing. Scientists can leverage the complex physics of subatomic particles to develop advanced computing systems.



In particular, physical matter has both&nbsp;particle and wave-like qualities. Quantum computing exploits this behavior using specialized hardware. Moreover, unlike in classical computing where there are two states of information &mdash; in the form zeroes and ones &mdash; but in quantum computing, there are qubits that can assume the states of zeroes and ones, as well as both states simultaneously through superposition.



Quantum computers will be useful for encryption and optimization as well as finding solutions for stochastic problems. The rise of generative artificial intelligence has created optimism around the potential of quantum computing systems, thereby causing certain <a href="https://investorplace.com/industries/technology/quantum-computing/">quantum computing stocks</a> to rally.



However, there are several quantum computing stocks investors should sell by 2025.



<h2>Quantum Computing (QUBT)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2019/07/Quantum1600-300x169.jpg" alt="A digital rendering of a circuit board and digital chip in neon colors to illustrate quantum computing"><div>Source: Shutterstock</div></div>Founded in 2018, Quantum Computing (NASDAQ:<a href="https://investorplace.com/stock-quotes/qubt-stock-quote/">QUBT</a>) or &ldquo;QCi&rdquo; is a pure-play startup that specializes in designing affordable quantum systems. The quantum computing startup has spent years developing its <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1758009/000121390024028799/ea0202448-10k_quantum.htm">core QCi technology</a>, which uses light and the versatility of its quantum mechanical properties for a variety of applications.



Moreover, QCi&rsquo;s Dirac systems make up the company&rsquo;s host of affordable quantum computing products, and these systems are both portable and low power.



Unfortunately for investors hoping to make a lucrative bet on an up-and-coming quantum computing company, QCi is technically a penny stock, trading at $0.70.



Not only is the stock a lot less liquid than larger cap stocks, but it is extremely volatile as well. Penny stock traders will probably enjoy trading a stock like QUBT, but the company&rsquo;s lack of sustainable revenue growth over the years makes it hard to recommend holding long-term.



On a year-to-date basis, QCi&rsquo;s share price has fallen 20%, although there may have been some bouts of volatility that generated quick gains for speculative investors. All in all, if you&rsquo;re a long-term investor, QCi is probably not worth holding afte4 2024.



<h2>Rigetti Computing (RGTI)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2023/05/quantum-computing1600-300x169.png" alt=""><div>Source: Bartlomiej K. Wroblewski / Shutterstock.com</div></div>Rigetti Computing (NASDAQ:<a href="https://investorplace.com/stock-quotes/rgti-stock-quote/">RGTI</a>) is a vertically integrated quantum computing startup that has made immense strides in the burgeoning field. The company has focused on developing quantum processors that go into actual quantum computing systems.



In the second quarter of fiscal year 2024, Rigetti <a href="https://investors.rigetti.com/news-releases/news-release-details/rigetti-computing-reports-first-quarter-2024-financial-results">revealed</a> it had achieved &ldquo;99.3% median 2-qubit gate fidelity&rdquo; on its 9-qubit Ankaa quantum processor. This achievement has given Rigetti confidence that it will be able to achieve a similar fidelity, with its larger 84-qubit Ankaa-3 system that should be available later in the year.



From there, Rigetti will work on building a 336-qubit Lyra.



The macroeconomic environment has put Rigetti in a complicated situation. Revenues declined the first time in a while for fiscal year 2023.



In particular, <a href="https://investors.rigetti.com/static-files/e055668b-c1b5-4001-8643-a1cb13fd1229">generated</a> $12 million in revenue, down more than 8% from fiscal year 2022. RGTI share price is also trading just above $1.00, which makes it more volatile than its worth for a long-term investor.



<h2>D-Wave Quantum (QBTS)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2022/09/quantum-computing-3-300x169.jpg" alt="A concept image showing a quantum computer with a matrix background; quantum computing. leading quantum stocks, Best Quantum Computing Stocks to Buy"><div>Source: Shutterstock</div></div>D-Wave Quantum (NYSE:<a href="https://investorplace.com/stock-quotes/qbts-stock-quote/">QBTS</a>) is the final quantum computing stock investors should avoid by 2025. D-Wave&rsquo;s <a href="https://www.dwavesys.com/solutions-and-products/systems/">Advantage system</a> is meant for enterprises, rather than research laboratories or institutions.



According to the company, the latest Advantage system comes with a new processor architecture with over 5,000 qubits and 15-way qubit connectivity.



Furthermore, D-Wave allows real-time access to its Advantage quantum computer via its &ldquo;<a href="https://www.dwavesys.com/solutions-and-products/cloud-platform/">Leap</a>&rdquo; quantum cloud service.



The use of cloud computing platforms to deliver quantum computing power is not a novel idea, as many quantum computing companies aim to improve the scalability of their quantum computing hardware.



D-Wave Quantum has performed better from a financial perspective than many of its counterparts, increasing sales steadily in recent years. Losses are another matter, however.



D-Wave&rsquo;s net loss has continued to balloon as it continues to develop new quantum systems.



What makes D-Wave a quantum computing stock to sell by 2025 is its stock price at $0.98 per share, making it volatile for long-term investors.



On the date of publication, Tyrik Torres did not hold (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines.</a>



On the date of publication, the responsible editor did not have (either directly or indirectly) any positions in the securities mentioned in this article.
<div>Tyrik Torres has been studying and participating in financial markets since he was in college, and he has particular passion for helping people understand complex systems. His areas of expertise are semiconductor and enterprise software equities. He has work experience in both investing (public and private markets) and investment banking.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>
The post <a href="https://investorplace.com/2024/07/get-your-money-out-of-these-3-quantum-computing-stocks-by-2025/">Get Your Money Out of These 3 Quantum Computing Stocks by 2025</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Get Your Money Out of These 3 Quantum Computing Stocks by 2025

A week ago it was suggested that the AI/semiconductor stocks sector was oversold. The decline bottomed on Wednesday and by the close of business this past Friday the sector had rebounded nicely almost across the board.

"Bubble" In AI/Semiconductor Stocks Began To Re-Inflate On Friday

Building a quantum computer is extremely expensive, complex and massive, and needs to be kept in stable laboratory conditions, and cooled to nearly absolute zero.

Pure-Play Quantum Computing Stocks Up 12% In July; Still Down 29% YTD

Quantum Computing receives Nasdaq non-compliance notice

Tech stocks plummeted Tuesday after the ISM manufacturing index reported August figures below consensus expectations. That  raised fears about the strength of the economy droving down the Quantum Computing Stocks Portfolio by 6.4% on the day.

Our Quantum Computing Stocks Portfolio Was Down 8% In August; Went Down +6% Yesterday

Tech stocks were -12.2%, on average, last week as a result of the ISM manufacturing index reporting August figures below consensus expectations raising fears about the strength of the economy and the Federal Reserve cutting interest rates.

Our Quantum Computing Portfolio Was -9.8% Week-Ending September 6th

Our Pure-Play Quantum Computing Stocks Portfolio only includes those companies that concentrate all their efforts on the research and development of quantum computing.to allow for a true comparison of performance by similar constituents.

Comments

Quantum Computing

Notizie

Ultime notizie per Quantum Computing (NASDAQ:QUBT) Azioni

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO